v3.25.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive (Loss) Gain
Accumulated Deficit
Balances, at Beginning of period at Dec. 31, 2022 $ 197,546 $ 3 $ 408,333 $ (1,813) $ (208,977)
Balances, at Beginning of period (in shares) at Dec. 31, 2022   40,287,097      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of shares under equity private placement, net of issuance costs of $264 129,736 $ 1 129,735    
Issuance of shares under equity private placement, net of issuance costs of $264 (in shares)   13,211,381      
Stock-based compensation expense 16,804   16,804    
Employee stock purchase plan expense 452   452    
Exercise of stock options 2,722   2,722    
Exercise of stock options (in shares)   733,867      
Issuance of shares under employee stock purchase plan 1,050   1,050    
Issuance of shares under employee stock purchase plan (in shares)   333,503      
Vesting of early exercised stock options $ 80   80    
Vesting of early exercised stock options (in shares) 2,329,483 18,640      
Vesting of restricted stock awards (in shares)   191,296      
Vesting of performance-based restricted stock unit awards (in shares)   217,000      
Net unrealized gain (loss) on marketable securities $ 2,160     2,160  
Net Income (Loss) (96,655)       (96,655)
Balances, at End of period at Dec. 31, 2023 253,895 $ 4 559,176 347 (305,632)
Balances, at End of period (in shares) at Dec. 31, 2023   54,992,784      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 22,009   22,009    
Employee stock purchase plan expense 573   573    
Issuance of shares and pre-funded warrants under equity private placement, net of issuance costs of $12,998 237,001 $ 2 236,999    
Issuance of shares and pre-funded warrants under equity private placement, net of issuance costs of $12,998 (in shares)   19,928,875      
Issuance of shares under at-the-market offering, net of issuance costs of $166 22,787   22,787    
Issuance of shares under at-the-market offering, net of issuance costs of $166 (in shares)   1,772,278      
Exchange of common stock shares for pre-funded warrants (in shares)   (3,420,000)      
Exercise of stock options $ 1,518   1,518    
Exercise of stock options (in shares) 460,744 430,159      
Issuance of shares under employee stock purchase plan $ 859   859    
Issuance of shares under employee stock purchase plan (in shares)   112,853      
Vesting of early exercised stock options (in shares) 2,213,715        
Vesting of restricted stock awards (in shares)   92,659      
Vesting of performance-based restricted stock unit awards (in shares)   403,000      
Net unrealized gain (loss) on marketable securities $ (204)     (204)  
Net Income (Loss) (129,474)       (129,474)
Balances, at End of period at Dec. 31, 2024 $ 408,964 $ 6 $ 843,921 $ 143 $ (435,106)
Balances, at End of period (in shares) at Dec. 31, 2024   74,312,608